MedTrace Logo

Eluvia DES for the Patients with Femoropopliteal Artery Lesions.

NCT05522218 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-09-27

No results posted yet for this study

Summary

This study is a multicenter, prospective, observational study, aiming to enroll 400 patients with peripheral arterial disease in the femoral-popliteal segment implanted with Eluvia stent. Each patient was followed up for 2 years. The technical success rate, target lesion patency rate, quality of life improvement, cost of Eluvia stent implantation, and other outcomes will be analysed.

Conditions

  • Vascular Diseases
  • Stent Complication

Interventions

DEVICE

Eluvia drug eluting stent

Eluvia drug eluting stent for peripheral arterial disease

Sponsors & Collaborators

  • First Affiliated Hospital of Zhejiang University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2025-08-01
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05522218 on ClinicalTrials.gov